Asset Management

Esperion Gets $33M To Continue Work On Cholesterol BusterThe Ann Arbor biotech firm Esperion Therapeutics Inc. announced that it has completed a $33 million preferred stock financing led by new investor Longitude Capital.
Event Notices From June 24-26The latest event and meeting notices from Michigan's technology-focused companies and institutions
Best Winter Festivals In Metro Detroit
Thanksgiving Parade Guide

Watch & Listen